Sensus Healthcare, Inc. (SRTS)
| Market Cap | 149.43M |
| Revenue (ttm) | 34.31M |
| Net Income (ttm) | 21.30M |
| Shares Out | 16.68M |
| EPS (ttm) | 1.29 |
| PE Ratio | 6.93 |
| Forward PE | 5.42 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 167,401 |
| Open | 8.98 |
| Previous Close | 8.94 |
| Day's Range | 8.87 - 9.07 |
| 52-Week Range | 3.08 - 11.96 |
| Beta | 0.52 |
| Analysts | Buy |
| Price Target | 14.59 (+62.8%) |
| Earnings Date | May 5, 2022 |
About SRTS
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, wh...
Financial Performance
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for SRTS stock is "Buy." The 12-month stock price forecast is 14.59, which is an increase of 62.83% from the latest price.
News
Correction: Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference
BOCA RATON, Fla, May 23, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective t...
Why Sensus Healthcare, Inc. (SRTS) Might be Well Poised for a Surge
Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts Think Sensus Healthcare, Inc. (SRTS) Could Surge 53%: Read This Before Placing a Bet
The consensus price target hints at a 52.9% upside potential for Sensus Healthcare, Inc. (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earn...
Sensus Healthcare to Participate in the H.C. Wainwright Global Investment Conference
BOCA RATON, Fla, May 18, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective t...
Sensus Healthcare, Inc. (SRTS) Beats Q1 Earnings and Revenue Estimates
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 233.33% and 65.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why "Trend" Investors Would Love Betting on Sensus Healthcare, Inc. (SRTS)
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our "...
Sensus Healthcare, Inc. (SRTS) Moves 7.3% Higher: Will This Strength Last?
Sensus Healthcare, Inc. (SRTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price ...
8 Micro-Cap Stocks to Buy for a Calculated Gamble
Despite the dismal start to 2022 for the market, micro-cap stocks like eight still offer significant growth potential for investors. The post 8 Micro-Cap Stocks to Buy for a Calculated Gamble appeared f...
Here's Why Sensus Healthcare, Inc. (SRTS) Could be Great Choice for a Bottom Fisher
Sensus Healthcare, Inc. (SRTS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions co...
Sensus Healthcare, Inc. (SRTS) Just Overtook the 20-Day Moving Average
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
Sensus Healthcare to Present at Two Investment Conferences in March
BOCA RATON, Fla. , March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effecti...
What Makes Sensus Healthcare, Inc. (SRTS) a Good Fit for "Trend Investing"
Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed ...
Sensus Healthcare Announces Share Repurchase Program
BOCA RATON, Fla, March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective...
Will Sensus Healthcare, Inc. (SRTS) Gain on Rising Earnings Estimates?
Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Sensus Healthcare Offloads Sculptura Assets To Focus On Core Dermatology Offerings
Sensus Healthcare Inc (NASDAQ: SRTS) sold its Sculptura assets to Empyrean Medical Systems for $15 million in cash. The sale included an inventory of Sculptura systems and parts, in addition to all rel...
Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash
Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion
Sensus Healthcare, Inc. (SRTS) is on the Move, Here's Why the Trend Could be Sustainable
If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our "...
Sensus Healthcare, Inc. (SRTS) Beats Q4 Earnings and Revenue Estimates
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of 128.57% and 18.31%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Sensus Healthcare Reports Record Sales and Earnings for the 2021 Fourth Quarter
4Q21 diluted EPS of $0.32 on revenues of $13.0 million up 433% and 156%, respectively
Sensus Healthcare, Inc. (SRTS) Earnings Expected to Grow: Should You Buy?
Sensus Healthcare, Inc. (SRTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Buy These 4 Low-Beta Stocks to Sail Through the Choppy Market
It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sensus Healthcare (SRTS), Stride, Inc. (LRN), Euroseas Ltd.
Sensus Healthcare Prepares Organization for Long-term Growth with Three Promotions
Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named Regional Vice Presidents of Sales Michael J. Sardano named President, Christopher Machuzak and Jeffrey Starling named ...
Sensus Healthcare, Inc. (SRTS) Just Reclaimed the 50-Day Moving Average
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Sensus Healthcare to Host Fourth Quarter 2021 Financial Results and Business Update Conference Call on February 10, 2022
BOCA RATON, Fla, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non...
5 Stocks With Recent Price Strength in a Volatile January
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are MCB, HBNC, SRTS, OCN and CBZ.